EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Yidu Tech's enterprise value is €-84.0 Mil.
Yidu Tech's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €103.3 Mil. Therefore, Yidu Tech's EV-to-Revenue for today is -0.81.
The historical rank and industry rank for Yidu Tech's EV-to-Revenue or its related term are showing as below:
STU:0EL'
s EV-to-Revenue Range Over the Past 10 Years
Min: -0.95 Med: 1.47 Max: 42.31
Current: -0.83
During the past 7 years, the highest EV-to-Revenue of Yidu Tech was 42.31. The lowest was -0.95. And the median was 1.47.
STU:0EL's EV-to-Revenue is ranked better than 99.25% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 1.78
vs STU:0EL: -0.83
As of today (2024-09-25), Yidu Tech's stock price is €0.348.
Yidu Tech's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.10. Therefore, Yidu Tech's PS Ratio for today is 3.52.
Yidu Tech EV-to-Revenue Historical Data
The historical data trend for Yidu Tech's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Yidu Tech's EV-to-Revenue
For the Health Information Services subindustry, Yidu Tech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yidu Tech's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yidu Tech's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Yidu Tech's EV-to-Revenue falls into.
Yidu Tech's current Enterprise Value is €-84.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yidu Tech's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €103.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yidu Tech's share price for today is €0.348.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Mar. 2024 was €0.10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yidu Tech EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Yidu Tech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Yidu Tech offers healthcare Big Data. It is an AI cloud-based firm providing solutions and tools to aid in more informed decisions to drive better efficiency in clients' strategies. Its clients are hospitals, pharmaceutical, biotech and medical device firms, research institutions, insurance companies, patients, and regulators. It three business segments are: Big Data platform and solutions, which partners with hospitals and policymakers to drive better efficiency; life sciences solutions, which enables better probability of clinical trial success with less drug development time and cost; and health management solutions, which helps with patient management. The Big Data platform accounted for 33% of revenue, life science solutions 30%, and health management solutions 27%, in fiscal 2022.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:0EL has been successfully added to your 